Hemorrhagic Stroke Clinical Trial
Official title:
Comparing the Benefits of Functional Recovery Between the Early Mobilization and Early Conventional Intervention After Stroke for the Patients With Mild to Moderate Hemorrhagic Stroke
Verified date | September 2018 |
Source | National Taiwan University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to examine the outcomes of early mobilization and early intervention within
24-72 hours after the onset of hemorrhagic stroke in patients admitted to an intensive care
unit within 24 hours after stroke. The patients after hemorrhagic stroke who undergo early
intervention only will be compared with those who also receive early mobilization in order to
determine if the early mobilization intervention results in earlier or more effective
recovery of postural stability, activities of daily living function, or motor capacity.
The participants will be randomly assigned to the following two groups: (1) the early
mobilization (+early rehabilitation) group and (2) the early rehabilitation group.The
measurement parameters will be collected before the intervention (basic parameters), two
weeks after the stroke, four weeks after the stroke and three months after the stroke. SPSS
(version 17.0) will be used to carry out repeated measures analysis of variance (repeated
ANOVA) to compare the differences between the groups at different time points (including
basic values and follow-up values). For statistical significance, Bonferroni correction will
be applied for the post-hoc analysis of the groups.
Status | Completed |
Enrollment | 60 |
Est. completion date | February 10, 2019 |
Est. primary completion date | November 9, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility |
The inclusion criteria will be as follows: 1. patients with a first time intracerebral (either cortical or subcortical) hemorrhage with unilateral hemiparesis/ hemiplegia confirmed by magnetic resonance imaging or computed tomography; 2. patients with no contraindications to being mobilized (early intervention) within 24 hours of stroke onset (based on the medical team's clinical judgment: including systolic blood pressure (SBP)<160mmHg in resting; resting heart rate (HR)<130 bpm; no hydrocephalus; 80< mean arterial pressure (MAP)<110 mmHg before intervention); 3. patients with National Institutes of Health Stroke Scale (NIHSS) scores at admission ranging from 1 to 20; 4. patients with total activity of living independence pre-stroke; and 5. patients between 20 and 80 years old. The exclusion criteria will be as follows: 1. patients with mild to moderate deficits as described above (3); 2. patients who are unable to complete the baseline survey because of serious aphasia, language difficulties, or cognitive deficits; 3. patients with other medical conditions, such as severe heart failure, acute coronary syndrome, or lower-limb disorders, that prevent early mobilization; and 4. patients who are unable to provide informed consent. In addition, we will exclude those showing rapid early deterioration of symptoms, as well as those with a concurrent diagnosis of rapidly deteriorating disease (e.g., terminal cancer). |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the score-change of the Functional Independence Measure (FIM) assessment for daily living function | The functional independence of patient's capacities in terms of activity of daily living. The instrument assesses motor domain including dependence in self-care, sphincter management, transfer, locomotion as well as cognition domain including communication, social interaction and cognition. | baseline, 2-week, 4-week and three months after stroke | |
Secondary | the number of days required to reach a sitting>5 minutes milestone | The milestone will be the ability to sit on the edge of a bed with the feet touching the floor without support > 5 minutes. | baseline to within 3 months after stroke | |
Secondary | the number of days required to reach a standing>1 minute milestone | The milestone will be the ability to stand without support for longer than 1 minute and with the feet freely positioned. | baseline to within 3 months after stroke | |
Secondary | the number of days required to reach a walking>50 meters milestone using the functional ambulation category (FAC) | The milestone will consist of walking on a level surface for a minimum of 50 meters with/without an assistive device while under supervision or required support level | baseline to within 3 months after stroke | |
Secondary | the number of serious adverse events | Immobility-related and neurological serious adverse events include both fatal and non-fatal complications; immobility-related events include pulmonary embolism, deep-vein thrombosis, urinary tract infection, pressure sores, pneumonia; and neurological events include stroke progression and recurrent stroke. | baseline to within 3 months after stroke | |
Secondary | the score-change of the Postural Assessment Scale for Stroke Patients (PASS) | 12 four-level items of varying difficulty with a maximum score of 36 | baseline, 2-week, 4-week and three months after stroke | |
Secondary | the score-change of systolic blood pressure (SBP) during the acute phase | recorded the absolute SBP values over time | up to 2 weeks after stroke | |
Secondary | the number of days required to stay in the stroke center | the length of stay in the stroke center | baseline to within 3 months after stroke |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Completed |
NCT01573117 -
A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1)
|
Phase 2 | |
Not yet recruiting |
NCT06069973 -
Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia
|
||
Not yet recruiting |
NCT05816213 -
Point-of-care Low-field MRI in Acute Stroke
|
||
Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
Recruiting |
NCT04534556 -
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke
|
N/A | |
Recruiting |
NCT04200781 -
Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
|
Phase 4 | |
Recruiting |
NCT05440682 -
Connectivity in Cranioplasty
|
N/A | |
Completed |
NCT05121415 -
Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
|
||
Terminated |
NCT02626377 -
Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté
|
N/A | |
Completed |
NCT01942031 -
Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke)
|
N/A | |
Completed |
NCT01845350 -
Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients
|
Phase 1 | |
Recruiting |
NCT05865795 -
Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
|
||
Completed |
NCT04612218 -
Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies
|
||
Recruiting |
NCT06134921 -
Effects of Transcranial Electrical Stimulation in Stroke Individuals
|
N/A | |
Recruiting |
NCT06190314 -
SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.
|
||
Recruiting |
NCT05735405 -
Aerobic Exercise and Cognitive Training in Patients With Stroke
|
N/A | |
Recruiting |
NCT06107725 -
Maimonides Minocycline in Stroke Study
|
Phase 2/Phase 3 | |
Completed |
NCT05916885 -
Effects of Short-intensity Modified Constraint-induced Movement Therapy on Hand Function in Stroke Patients.
|
N/A |